Provided by Tiger Trade Technology Pte. Ltd.

Alnylam Pharmaceuticals

248.68
+1.170.47%
Post-market: 255.006.32+2.54%17:18 EDT
Volume:1.18M
Turnover:294.95M
Market Cap:33.18B
PE:44.25
High:254.08
Open:248.05
Low:246.01
Close:247.51
52wk High:495.55
52wk Low:197.81
Shares:133.43M
Float Shares:133.16M
Volume Ratio:0.72
T/O Rate:0.88%
Dividend:- -
Dividend Rate:- -
EPS(TTM):5.62
EPS(LYR):2.33
ROE:96.55%
ROA:12.34%
PB:24.50
PE(LYR):106.73

Loading ...

Outside Review Warns Alnylam Pharmaceuticals Stock Carries High Risk of Significant Losses

TIPRANKS
·
May 01

Analysts Offer Insights on Healthcare Companies: Alnylam Pharma (ALNY) and Alignment Healthcare (ALHC)

TIPRANKS
·
May 01

Alnylam reports Q1 EPS $1.99, consensus $1.47

TIPRANKS
·
May 01

Sector Update: Health Care Stocks Rise Premarket Thursday

MT Newswires Live
·
Apr 30

Alnylam Q1 FY26 GAAP net income swings to USD 205.99 million; revenue rises 96% to USD 1.17 billion

Reuters
·
Apr 30

Alnylam Pharmaceuticals Shares up 7.9% Premarket After Q1 Profit Beat

THOMSON REUTERS
·
Apr 30

GUIDANCE: (ALNY) Alnylam Pharmaceuticals Expects 2026 Total Net Product Revenue Range $4.90B - $5.30B

MT Newswires Live
·
Apr 30

Alnylam Q1 net product revenue jumps 121%, adjusted EPS beats estimates

Reuters
·
Apr 30

Stock Track | Alnylam Pharmaceuticals Soars 6.25% in Pre-Market on Strong Q1 Earnings Beat and Revenue Growth

Stock Track
·
Apr 30

Alnylam Pharmaceuticals Q1 Adj. EPS $1.99 Beats $0.93 Estimate, Sales $1.167B Beat $1.114B Estimate

Benzinga Earnings
·
Apr 30

Alnylam Pharmaceuticals Reports First Quarter 2026 Financial Results and Highlights Recent Period Progress

THOMSON REUTERS
·
Apr 30

Alnylam Pharmaceuticals Q1 Adjusted EPS USD 1.99 VS. Ibes Estimate USD 0.95

THOMSON REUTERS
·
Apr 30

Corrected-Alnylam Pharmaceuticals Q1 Net Product Revenue USD 1,036 Million

THOMSON REUTERS
·
Apr 30

Alnylam Pharmaceuticals Q1 Adjusted Operating Income USD 338.79 Million

THOMSON REUTERS
·
Apr 30

Alnylam Pharmaceuticals Inc: Reiterates 2026 Financial Guidance

THOMSON REUTERS
·
Apr 30

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Apr 30

3 Stocks Estimated To Be Trading Below Intrinsic Value By Up To 35.4%

Simply Wall St.
·
Apr 30

H.C. Wainwright Remains a Buy on Alnylam Pharma (ALNY)

TIPRANKS
·
Apr 29

April 2026's Top 3 Stocks That May Be Trading Below Estimated Fair Value

Simply Wall St.
·
Apr 28

BUZZ - Nasdaq top and bottom performing stocks at about 11:01 a.m. EDT on 2026-04-27

Reuters
·
Apr 27